Aurora Investment Counsel Amphastar Pharmaceuticals, Inc. Transaction History

Aurora Investment Counsel

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 30, 2025	SELL	$22.96 - $28.29 $19,010 - $23,424	-828 Reduced 1.53%	53,253 $1.22 Million
Q1 2025 May 01, 2025	SELL	$26.24 - $38.48 $16,373 - $24,011	-624 Reduced 1.14%	54,081 $1.57 Million
Q4 2024 Feb 10, 2025	BUY	$36.84 - $53.4 $257 - $373	7 Added 0.01%	54,705 $2.03 Million
Q3 2024 Nov 08, 2024	BUY	$36.99 - $50.09 $8,581 - $11,620	232 Added 0.43%	54,698 $2.65 Million
Q2 2024 Aug 22, 2024	BUY	$38.65 - $43.48 $2.11 Million - $2.37 Million	54,466 New	54,466 $2.18 Million

263

33.5M

73.4K

12.6K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.28B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Aurora Investment Counsel, based on Form 13F filings with the SEC.

Stay updated on Aurora Investment Counsel with notifications on news.